StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Taltz by Quarter

Taltz — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY through FY2024] (%)

QuarterlyAnnual

Eli Lilly Taltz: 1.0% in Q2 2026, down 284.3 pts from a year earlier.

Latest, Q2 2026
1.0%
Period ended Jun 30, 2026
Change on a year earlier
-284.3 pts
285.3% in Q2 2025
History
31 quarters
Since Q1 2018
Sources
31
Documents cited below

Where the Q2 2026 figure comes from

“|| Taltz | 539 | 317 | 856 | 848 | 1”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q MD&A & Form 10-K through FY2024.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTaltz — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY through FY2024] (%)Year on yearSource
Q2 2026Jun 30, 20261.0%-284.3 ptsForm 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026-4.0%-261.0 ptsForm 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q3 2025Sep 30, 2025279.3%+261.3 ptsForm 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025285.3%+268.3 ptsForm 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 2025257.0%+242.0 ptsForm 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q4 2024Dec 31, 202421.0%+10.0 ptsEarnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 202418.0%+9.0 ptsForm 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 202417.0%+1.0 ptsForm 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 202415.0%+7.0 ptsForm 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q4 2023Dec 31, 202311.0%+2.0 ptsEarnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 20239.0%-6.0 ptsForm 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 202316.0%+9.0 ptsForm 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 20238.0%-13.0 ptsForm 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 20229.0%-22.0 ptsEarnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 202215.0%-15.0 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗
Q2 2022Jun 30, 20227.0%-37.0 ptsForm 10-Q FY2022Q2 (filed 2022-08-04) ↗

Cite this data

StockData. (2026). Eli Lilly Taltz (%), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-taltz-yoy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.